These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11152061)

  • 41. Safety and efficacy of NT, an herbal supplement, in treating human obesity.
    Greenway FL; Liu Z; Martin CK; Kai-yuan W; Nofziger J; Rood JC; Yu Y; Amen RJ
    Int J Obes (Lond); 2006 Dec; 30(12):1737-41. PubMed ID: 16652135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of a polysaccharide-rich hydrolysate from Saccharomyces cerevisiae (LipiGo®) in body weight loss: randomised, double-blind, placebo-controlled clinical trial in overweight and obese adults.
    Santas J; Lázaro E; Cuñé J
    J Sci Food Agric; 2017 Sep; 97(12):4250-4257. PubMed ID: 28251654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.
    Garrison R; Chambliss WG
    Altern Ther Health Med; 2006; 12(1):50-4. PubMed ID: 16454147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A caffeine containing weight loss supplement augments hemodynamic responses after exercise.
    Buchanan SR; Karabulut M
    Int J Cardiol; 2018 Feb; 253():133-137. PubMed ID: 29306453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.
    Astrup A; Buemann B; Christensen NJ; Toubro S; Thorbek G; Victor OJ; Quaade F
    Metabolism; 1992 Jul; 41(7):686-8. PubMed ID: 1619985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential toxicity of caffeine when used as a dietary supplement for weight loss.
    Pendleton M; Brown S; Thomas CM; Odle B
    J Diet Suppl; 2013 Mar; 10(1):1-5. PubMed ID: 23374013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thermal regulation in the heat during exercise after caffeine and ephedrine ingestion.
    Bell DG; Jacobs I; McLellan TM; Miyazaki M; Sabiston CM
    Aviat Space Environ Med; 1999 Jun; 70(6):583-8. PubMed ID: 10373050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ingesting a preworkout supplement containing caffeine, creatine, β-alanine, amino acids, and B vitamins for 28 days is both safe and efficacious in recreationally active men.
    Kendall KL; Moon JR; Fairman CM; Spradley BD; Tai CY; Falcone PH; Carson LR; Mosman MM; Joy JM; Kim MP; Serrano ER; Esposito EN
    Nutr Res; 2014 May; 34(5):442-9. PubMed ID: 24916558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic, cardiovascular, and perceptual responses to a thermogenic nutritional supplement at rest, during exercise, and recovery in men.
    Bergstrom HC; Housh TJ; Traylor DA; Lewis RW; Cochrane KC; Jenkins ND; Schmidt RJ; Johnson GO; Housh DJ; Cramer JT
    J Strength Cond Res; 2014 Aug; 28(8):2154-63. PubMed ID: 24513614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary Caffeine and Polyphenol Supplementation Enhances Overall Metabolic Rate and Lipid Oxidation at Rest and After a Bout of Sprint Interval Exercise.
    Jo E; Lewis KL; Higuera D; Hernandez J; Osmond AD; Directo DJ; Wong M
    J Strength Cond Res; 2016 Jul; 30(7):1871-9. PubMed ID: 27331913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ephedrine, caffeine and aspirin: "over-the-counter" drugs that interact to stimulate thermogenesis in the obese.
    Dulloo AG; Miller DS
    Nutrition; 1989; 5(1):7-9. PubMed ID: 2520262
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects.
    Pasquali R; Casimirri F; Melchionda N; Grossi G; Bortoluzzi L; Morselli Labate AM; Stefanini C; Raitano A
    Clin Sci (Lond); 1992 Jan; 82(1):85-92. PubMed ID: 1310922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
    Toubro S; Astrup A; Breum L; Quaade F
    Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S73-7; discussion S82. PubMed ID: 8124407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ingesting caffeine and ephedrine on 10-km run performance.
    Bell DG; McLellan TM; Sabiston CM
    Med Sci Sports Exerc; 2002 Feb; 34(2):344-9. PubMed ID: 11828246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
    Breum L; Pedersen JK; Ahlstrøm F; Frimodt-Møller J
    Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caffeine Transiently Affects Food Intake at Breakfast.
    Panek-Shirley LM; DeNysschen C; O'Brien E; Temple JL
    J Acad Nutr Diet; 2018 Oct; 118(10):1832-1843. PubMed ID: 30033159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women.
    Waluga M; Janusz M; Karpel E; Hartleb M; Nowak A
    Clin Physiol; 1998 Jan; 18(1):69-76. PubMed ID: 9545623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A beating heart cell model to predict cardiotoxicity: effects of the dietary supplement ingredients higenamine, phenylethylamine, ephedrine and caffeine.
    Calvert R; Vohra S; Ferguson M; Wiesenfeld P
    Food Chem Toxicol; 2015 Apr; 78():207-13. PubMed ID: 25684415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults.
    Mhurchu CN; Poppitt SD; McGill AT; Leahy FE; Bennett DA; Lin RB; Ormrod D; Ward L; Strik C; Rodgers A
    Int J Obes Relat Metab Disord; 2004 Sep; 28(9):1149-56. PubMed ID: 15311218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A controlled trial using ephedrine in the treatment of obesity.
    Pasquali R; Baraldi G; Cesari MP; Melchionda N; Zamboni M; Stefanini C; Raitano A
    Int J Obes; 1985; 9(2):93-8. PubMed ID: 3897082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.